123 related articles for article (PubMed ID: 33302150)
1. Immobilisation of CXCL8 gradients in microfluidic devices for migration experiments.
Kilb MF; Engemann VI; Siddique A; Stark RW; Schmitz K
Colloids Surf B Biointerfaces; 2021 Feb; 198():111498. PubMed ID: 33302150
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
[TBL] [Abstract][Full Text] [Related]
3. A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients.
Schwarz J; Bierbaum V; Merrin J; Frank T; Hauschild R; Bollenbach T; Tay S; Sixt M; Mehling M
Sci Rep; 2016 Nov; 6():36440. PubMed ID: 27819270
[TBL] [Abstract][Full Text] [Related]
4. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
Crijns H; Vanheule V; Proost P
Front Immunol; 2020; 11():483. PubMed ID: 32296423
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
Joseph PRB; Sawant KV; Rajarathnam K
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
[TBL] [Abstract][Full Text] [Related]
6. A haptotaxis assay for leukocytes based on surface-bound chemokine gradients.
Rink I; Rink J; Helmer D; Sachs D; Schmitz K
J Immunol; 2015 Jun; 194(11):5549-58. PubMed ID: 25917105
[TBL] [Abstract][Full Text] [Related]
7. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
8. Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.
McNaughton EF; Eustace AD; King S; Sessions RB; Kay A; Farris M; Broadbridge R; Kehoe O; Kungl AJ; Middleton J
J Immunol; 2018 May; 200(9):3201-3217. PubMed ID: 29572348
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.
Derler R; Gesslbauer B; Weber C; Strutzmann E; Miller I; Kungl A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207576
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte responses to immobilized patterns of CXCL8.
Girrbach M; Rink I; Ladnorg T; Azucena C; Heißler S; Haraszti T; Schepers U; Schmitz K
Colloids Surf B Biointerfaces; 2016 Jun; 142():385-391. PubMed ID: 26970827
[TBL] [Abstract][Full Text] [Related]
11. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
[TBL] [Abstract][Full Text] [Related]
13. TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8.
Dyer DP; Thomson JM; Hermant A; Jowitt TA; Handel TM; Proudfoot AE; Day AJ; Milner CM
J Immunol; 2014 Mar; 192(5):2177-85. PubMed ID: 24501198
[TBL] [Abstract][Full Text] [Related]
14. Polydimethylsiloxane-polycarbonate Microfluidic Devices for Cell Migration Studies Under Perpendicular Chemical and Oxygen Gradients.
Chiang HJ; Yeh SL; Peng CC; Liao WH; Tung YC
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287582
[TBL] [Abstract][Full Text] [Related]
15. Profiling heparin-chemokine interactions using synthetic tools.
de Paz JL; Moseman EA; Noti C; Polito L; von Andrian UH; Seeberger PH
ACS Chem Biol; 2007 Nov; 2(11):735-44. PubMed ID: 18030990
[TBL] [Abstract][Full Text] [Related]
16. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
Sepuru KM; Rajarathnam K
J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans located on neutrophils and monocytes impact on CXCL8- and CCL2-induced cell migration.
Gerlza T; Nagele M; Mihalic Z; Trojacher C; Kungl A
Cytokine; 2021 Jun; 142():155503. PubMed ID: 33781652
[TBL] [Abstract][Full Text] [Related]
18. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
[TBL] [Abstract][Full Text] [Related]
19. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans.
Webb LM; Smith VP; Alcami A
FASEB J; 2004 Mar; 18(3):571-3. PubMed ID: 14734646
[TBL] [Abstract][Full Text] [Related]
20. T cell chemotaxis in a simple microfluidic device.
Lin F; Butcher EC
Lab Chip; 2006 Nov; 6(11):1462-9. PubMed ID: 17066171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
